speb/financial-data huggingface dataset:
COROMANDEL.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 15335200000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 5717100000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Other Payable: 651800000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 651800000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Other Properties: 649700000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 649700000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 25871600000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 25871600000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 18718700000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 18718700000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Other Special Charges: 49800000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Payables: 38890000000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Payables: 38890000000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 111700000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 806100000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 806100000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 5633000000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 5633000000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Pretax Income: 26171400000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 2276500000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Properties: 9407900000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Properties: 9407900000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 394700000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -8102100000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -16554900000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -15404700000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 31375200000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 31375200000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 238212200000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 43189400000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 5336200000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1647300000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 231800000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 231800000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -1580100000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -517900000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 514100000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 514100000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 98581400000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 98581400000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 39707000000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 44600000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 15770300000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3525200000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 16337300000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3525200000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Share Issued: 295014639.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 295014639.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Special Income Charges: -949900000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -705600000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 57400000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 125578900000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 125578900000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 116549800000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 116549800000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 97119000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -282240000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Tax Provision: 7190000000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 1130100000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.27
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 510300000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 510300000.00
COROMANDEL.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -7302700000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Assets: 245034300000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 245034300000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 126382300000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 126382300000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Debt: 65282900000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 65282900000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 131331900000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 131331900000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Total Expenses: 173462400000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 56806100000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 113702400000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 113702400000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 86563500000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 86563500000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 9048000000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 9048000000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 222900000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 17200000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 17200000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 1065300000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -705600000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 359700000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -705600000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 519800.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 519800.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Treasury Stock: 884500000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 884500000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Work In Process: 3827800000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 3827800000.00
COROMANDEL.NS balance_sheet (annual, 2026-03-31) — Working Capital: 53816400000.00
COROMANDEL.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 53816400000.00
COROMANDEL.NS income_statement (annual, 2026-03-31) — Write Off: 71700000.00
COROMANDEL.NS income_statement (quarterly, 2026-03-31) — Write Off: 705600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 14297700000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 81647700000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 294524362.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 12.93
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 61821100000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 2027600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 2027600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 294752322.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 12.92
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 3808200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — EBIT: 6027000000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — EBITDA: 8054600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 19826600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 890200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 890200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Minority Interests: -7400000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Income: 3808200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 3808200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 3815600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 3808200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 3808200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 3815600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -890200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -890200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 8054600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 3808200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Operating Income: 5528900000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 81647700000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 498100000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 4948400000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 5136800000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 61821100000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 2027600000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Selling And Marketing Expense: 4313400000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Selling General And Administration: 4313400000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Special Income Charges: 0.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 1321200000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.26
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 76118800000.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items: 0.00
COROMANDEL.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CORONA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 5644880000.00
CORONA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 8835280000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 943700000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 869910000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -289180000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 415840000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -2910000.00
CORONA.NS income_statement (annual, 2023-03-31) — Amortization: 90730000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 90730000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 144710000.00
CORONA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 61160088.00
CORONA.NS income_statement (annual, 2023-03-31) — Basic EPS: 13.89
CORONA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 68240000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 800490000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -947580000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 256290000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 144940000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 204630000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -69720000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 144940000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -314540000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 107540000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 170150000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Change In Payable: 98280000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -129320000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -49150000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 77080000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4085200000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 733530000.00
CORONA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 2109540000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 2914890000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 17920000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 23310000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 41230000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1373710000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 169780000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Depreciation: 110300000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 201030000.00
CORONA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 201030000.00
CORONA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 110300000.00
CORONA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 61160088.00
CORONA.NS income_statement (annual, 2023-03-31) — Diluted EPS: 13.89
CORONA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 849290000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 0.00
CORONA.NS income_statement (annual, 2023-03-31) — EBIT: 1132720000.00
CORONA.NS income_statement (annual, 2023-03-31) — EBITDA: 1333750000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -380000.00
CORONA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 144940000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 610000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -447470000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 674210000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 79420000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -2460000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 200000.00
CORONA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 886870000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 5340000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 872820000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2863310000.00
CORONA.NS income_statement (annual, 2023-03-31) — Gross Profit: 6725740000.00
CORONA.NS income_statement (annual, 2023-03-31) — Interest Expense: 23850000.00
CORONA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 23850000.00
CORONA.NS income_statement (annual, 2023-03-31) — Interest Income: 59750000.00
CORONA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 59750000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -43750000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 59750000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Inventory: 1054010000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 4108510000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -502450000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 145320000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 254540000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 81790000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 238370000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 0.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 238370000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
CORONA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -316710000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 254540000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 143330000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1100590000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 930000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Income: 849290000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 849290000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 849290000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 849290000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 849290000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1108870000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 849290000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Interest Income: 17070000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 375880000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -314070000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -316710000.00
CORONA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 17070000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2574130000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -938080000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 2640000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4079860000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 42520000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 104720000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 8950000.00
CORONA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1333390000.00
CORONA.NS income_statement (annual, 2023-03-31) — Normalized Income: 849014273.90
CORONA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1027000000.00
CORONA.NS income_statement (annual, 2023-03-31) — Operating Income: 1080860000.00
CORONA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 8835280000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 61160088.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 5340000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 64570000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -17630000.00
CORONA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 2680000.00
CORONA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 948600000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 153390000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 146910000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 7050000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 59690000.00
CORONA.NS income_statement (annual, 2023-03-31) — Other Special Charges: 200000.00
CORONA.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Payables: 1135410000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 14660000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 157270000.00
CORONA.NS income_statement (annual, 2023-03-31) — Pretax Income: 1108870000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
CORONA.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 43810000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -174280000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -947580000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 256550000.00
CORONA.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 2109540000.00
CORONA.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 201030000.00
CORONA.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 180000.00
CORONA.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 180000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -316710000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 622020000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 3057760000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 550160000.00
CORONA.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 9500000.00
CORONA.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1065710000.00
CORONA.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1952580000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Share Issued: 61160088.00
CORONA.NS income_statement (annual, 2023-03-31) — Special Income Charges: -2100000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 4085200000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4079860000.00
CORONA.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 84273.90
CORONA.NS income_statement (annual, 2023-03-31) — Tax Provision: 259580000.00
CORONA.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.23
CORONA.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -258220000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Assets: 5950240000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 4085200000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Debt: 279600000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 4085200000.00
CORONA.NS income_statement (annual, 2023-03-31) — Total Expenses: 7754420000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1865040000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3035350000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 491330000.00
CORONA.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 18830000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 38320000.00
CORONA.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 360000.00
CORONA.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 360000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Work In Process: 58680000.00
CORONA.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1541180000.00
CORONA.NS income_statement (annual, 2023-03-31) — Write Off: 1900000.00
CORONA.NS income_statement (annual, 2024-03-31) — +Operating Expense: 6590200000.00
CORONA.NS income_statement (annual, 2024-03-31) — +Total Revenue: 10136820000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1142950000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 999340000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -412150000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 415840000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -1380000.00
CORONA.NS income_statement (annual, 2024-03-31) — Amortization: 153120000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 153120000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 19650000.00
CORONA.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 61160088.00
CORONA.NS income_statement (annual, 2024-03-31) — Basic EPS: 14.80
CORONA.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 144940000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 813710000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2863400000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 248130000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 31560000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 31560000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -169410000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 31560000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 64710000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -56790000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -11990000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Change In Payable: 201160000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -126630000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 93150000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -113400000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Common Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 4804070000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1279890000.00
CORONA.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 2268280000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Current Assets: 2899160000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 21650000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Current Debt: 671420000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 693070000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2241920000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 224960000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Depreciation: 129660000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 282780000.00
CORONA.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 282780000.00
CORONA.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 129660000.00
CORONA.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 61160088.00
CORONA.NS income_statement (annual, 2024-03-31) — Diluted EPS: 14.80
CORONA.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 905030000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 0.00
CORONA.NS income_statement (annual, 2024-03-31) — EBIT: 1299760000.00
CORONA.NS income_statement (annual, 2024-03-31) — EBITDA: 1582540000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 20000.00
CORONA.NS cash_flow (annual, 2024-03-31) — End Cash Position: 31560000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 740000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 985450000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 675430000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -1295820000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -2560000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 12050000.00
CORONA.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1015400000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1926930000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1000720000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 3602110000.00
CORONA.NS income_statement (annual, 2024-03-31) — Gross Profit: 7868540000.00
CORONA.NS income_statement (annual, 2024-03-31) — Interest Expense: 114950000.00
CORONA.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 114950000.00
CORONA.NS income_statement (annual, 2024-03-31) — Interest Income: 46650000.00
CORONA.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 46650000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -144660000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 46650000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Inventory: 983450000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 6145490000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2666430000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 20390000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 254610000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 1800000000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 81790000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 226480000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 670000000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 896480000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 1800000000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -770000000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 254610000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 166090000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1270540000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Net Debt: 1309860000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -1800000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Income: 905030000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 905030000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 905030000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 905030000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 905030000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 1184810000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 905030000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Interest Income: -97720000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 144610000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 1318110000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 1030000000.00
CORONA.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -97720000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Net PPE: 3189960000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -2857690000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 288110000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2877140000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 0.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 42860000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 154200000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 12080000.00
CORONA.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1592240000.00
CORONA.NS income_statement (annual, 2024-03-31) — Normalized Income: 912439830.00
CORONA.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1567580000.00
CORONA.NS income_statement (annual, 2024-03-31) — Operating Income: 1278340000.00
CORONA.NS income_statement (annual, 2024-03-31) — Operating Revenue: 10136820000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 61160088.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 1926930000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 50380000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 95790000.00
CORONA.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 8960000.00
CORONA.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1215890000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Other Payable: 111360000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Other Properties: 156180000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 7760000.00
CORONA.NS income_statement (annual, 2024-03-31) — Other Special Charges: 12050000.00
CORONA.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Payables: 1302360000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10250000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 209580000.00
CORONA.NS income_statement (annual, 2024-03-31) — Pretax Income: 1184810000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
CORONA.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 82260000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
CORONA.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -2863400000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 192400000.00
CORONA.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 2268280000.00
CORONA.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 282780000.00
CORONA.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 60000.00
CORONA.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 60000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -770000000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 667470000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 3776630000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 144610000.00
CORONA.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 5710000.00
CORONA.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1130320000.00
CORONA.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2145720000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Share Issued: 61160088.00
CORONA.NS income_statement (annual, 2024-03-31) — Special Income Charges: -12260000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 4804070000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2877140000.00
CORONA.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -2290170.00
CORONA.NS income_statement (annual, 2024-03-31) — Tax Provision: 279780000.00
CORONA.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.24
CORONA.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -179050000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Assets: 8305760000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 5474070000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1589550000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 4804070000.00
CORONA.NS income_statement (annual, 2024-03-31) — Total Expenses: 8858480000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3501690000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 5406600000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1259770000.00
CORONA.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 29420000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 48050000.00
CORONA.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -9700000.00
CORONA.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -9700000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Work In Process: 65240000.00
CORONA.NS balance_sheet (annual, 2024-03-31) — Working Capital: 657240000.00
CORONA.NS income_statement (annual, 2024-03-31) — Write Off: 210000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1827600000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 2976900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 7.35
CORONA.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 552000000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 96900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 96900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 7.35
CORONA.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — EBIT: 606700000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — EBITDA: 703600000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 2424900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 23900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 23900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Income: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -23900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -23900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 703600000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 449500000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Operating Income: 597300000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 2976900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 7600000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 836000000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 582800000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 552000000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 96900000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 133300000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.23
CORONA.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 2379600000.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
CORONA.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CORONA.NS income_statement (annual, 2025-03-31) — +Operating Expense: 7553900000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1926500000.00
CORONA.NS income_statement (annual, 2025-03-31) — +Total Revenue: 11955100000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2936900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1435200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1435200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1182900000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1182900000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -529800000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -529800000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 415800000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 415800000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
CORONA.NS income_statement (annual, 2025-03-31) — Amortization: 217700000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 217700000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 100000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 100000.00
CORONA.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 61160088.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 61160088.00
CORONA.NS income_statement (annual, 2025-03-31) — Basic EPS: 24.43
CORONA.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 5.16
CORONA.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 31600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 824500000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 824500000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -916600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 235400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 235400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 611600000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 32200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 32200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 32200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 32200000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -226300000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 32200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 32200000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -333900000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -1100000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 26100000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Change In Payable: 294200000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -183000000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -170700000.00
CORONA.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Common Stock: 611600000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 611600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 6063400000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6063400000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1938300000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1938300000.00
CORONA.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 2365200000.00
CORONA.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 568600000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Current Assets: 3388700000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 3388700000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 25200000.00
CORONA.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 25200000.00
CORONA.NS balance_sheet (annual, 2025-03-31) — Current Debt: 467000000.00